Vitamin B12 for Fatigue

Verdict: Published

Across 6 PubMed studies, the evidence for Vitamin B12 in Fatigue grades Tier C — weak evidence.

C 🟠 C Weak Evidence Published

🔬Why this grade7-layer evidence engine

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published
Confidence
86%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.52
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.477
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression
PMID: 33809274 2021 統合分析 n = 6,276
Finding: Across 16 RCTs (n=6,276) B12 (alone or with folate/B6) showed no significant effect on any cognitive subdomain or on depressive symptoms, and fatigue could not be pooled because only 1 of 16 trials reported it (k=1, no meta-analytic estimate possible).
🟢 High quality Academic Effect size: Fatigue: not pooled (k=1); cognition/depression SMD non-significant
View on PubMed
Surplus vitamin B12 use does not reduce fatigue in patients with Irritable Bowel Syndrome or inflammatory bowel disease: A randomized double-blind placebo-controlled trial
PMID: 29460813 2018 RCT (double-blind) n = 95
Finding: Oral cyanocobalamin 1000 ug/day for 8 weeks produced a CIS-fatigue change of -8.1 +/- 9.5 versus -8.3 +/- 10.6 for placebo (between-group difference non-significant, 95% CI -11.65 to 6.71); only the motivation subscale favored B12 (-2.2, 95% CI -4.4 to -0.04).
Effect size: Between-group fatigue difference NS (95% CI -11.65 to 6.71); motivation subscale -2.2 (95% CI -4.4 to -0.04)
View on PubMed
A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial
PMID: 37786445 2023 RCT (double-blind) n = 32
Finding: B-complex increased running time to exhaustion 1.26-fold versus placebo (p<0.05) and significantly lowered blood lactate and ammonia during and after exercise (p<0.05); however participants were healthy and not screened for deficiency, and endpoints are exercise-performance/biochemical surrogates rather than a validated clinical fatigue scale.
🟠 Limited quality Effect size: Time to exhaustion +1.26-fold vs placebo (p<0.05); lactate and ammonia significantly reduced (p<0.05)
View on PubMed
Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study
PMID: 38797248 2024 Cohort n = 26
Finding: Oral cyanocobalamin 1000 ug/day corrected deficiency in 88.5% of patients by 1 month with significant rises in plasma B12 and falls in homocysteine and MMA (all P<0.0001); deficiency-related symptoms including fatigue improved alongside biochemical correction, but there was no placebo arm and fatigue was not separately quantified.
Academic Effect size: 88.5% repleted at 1 month; B12/homocysteine/MMA all P<0.0001 (single-arm)
View on PubMed
Clinical and Hematological Characteristics of Vitamin B12 Deficiency and Evaluation of the Therapeutic Response to Vitamin B12 Supplementation
PMID: 39867066 2024 Cohort n = 180
Finding: In overtly deficient adults, fatigue was the most common baseline symptom (66.7%); 6 weeks of weekly IM cyanocobalamin 1000 ug reversed macrocytic anemia (Hb 9.7 to 12.6 g/dL; MCV 104.7 to 91.3 fL) and improved fatigue/neurologic symptoms, with Hb correlating with B12 level (r=0.75, p<0.001); single-arm pre/post, no placebo.
🟠 Limited quality Academic Effect size: Hb +2.9 g/dL; MCV -13.4 fL; Hb-B12 correlation r=0.75 (p<0.001)
View on PubMed
A Systematic Review of Symptoms of Pernicious Anemia
PMID: 38987871 2024 系統性回顧 n = 103
Finding: Across 103 documented PA cases, fatigue was the single most common symptom (55%), ahead of loss of limb sensation (32%), weight loss (27%) and sore tongue (23%), confirming fatigue as a core, prevalent manifestation of B12-deficiency states that resolves with repletion.
🟠 Limited quality Academic Effect size: Fatigue prevalence 55% (most common symptom)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established source↗
L4c UK NHS
Supportive
Adults aged 19 to 64 need about 1.5 micrograms a day of vitamin B12. source↗
L4d TW TFDA / 衛福部
Supportive
維生素B12之足夠攝取量(AI)成人為每日2.4微克 source↗
L4e WHO
Supportive
Vitamin B12 or folate supplementation during pregnancy is not recommended as an intervention to improve maternal and infant health outcomes source↗
L5a NIH Office of Dietary Supplements
Supportive
Vitamin B12 supplementation appears to have no beneficial effect on performance in the absence of a nutritional deficit. source↗
L5c Cleveland Clinic
Cautious
Fatigue and weakness are common symptoms of vitamin B12 deficiency source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-fatigue-INT-vitamin-b12-001 繁體中文版 →